Digestive Health

In Vitro Inhibition of Pathogens by Polyols: Optical Density-Based Screening and Implications for the Oral–Systemic Axis

D-allulose alleviates DSS-induced colitis via regulating gut microbiota and bile acid metabolism

Unveiling the impact of allulose on oral microbiota and biofilm formation via a cariogenic potential assessment platform

Impact of non-nutritive sweeteners on bacterial quorum sensing and phenotypic expression: implications for gut microbiome dynamics

Gut microbial utilization of the alternative sweetener, D-allulose, via AlsE

Gut microbial utilization of the alternative sweetener, D-allulose, via AlsE

D-Psicose mitigates NAFLD mice induced by a high-fat diet by reducing lipid accumulation, inflammation, and oxidative stress

d-Allulose and erythritol increase butyrate production and impact the gut microbiota in healthy adults and adults with type-2 diabetes ex vivo

D-allulose attenuated metaflammation by calming adipose tissue macrophages, boosting intestinal barrier, and modulating gut microbiota in HFD mice

Gastrointestinal tolerance of D-allulose in healthy and young adults. A non-randomized controlled trial

Comparative effects of allulose, fructose, and glucose on the small intestine

Alteration of microbiome profile by D‐allulose in amelioration of high‐fat‐diet‐induced obesity in mice

Evaluation of the site specific protein glycation and antioxidant capacity of rare sugar-protein/peptide conjugates

Neuroprotective effect of D-psicose on 6-hydroxydopamine-induced apoptosis in rat pheochromocytoma (PC12) cells

Less body fat accumulation with D-psicose diet versus D-fructose diet